Antimicrobial resistance, one of the world’s biggest killers, has reached an alarming tipping point.

Changing the way antibiotics are developed and accessed.

A public-health driven model to tackle AMR.

Our latest news and resources.

Protecting people from the rise and spread of drug-resistant infections.

Supporting efforts to ensure the right antibiotics are developed and reach the people who need them.

Press releases.

Filter by

Image Zoliflodacin sachet Thailand
Sexually transmitted infections
Partners

Thai FDA approves NUZOLVENCE® (zoliflodacin) just six months after US authorization

Read more
African american female Doctor in the operating room putting drugs through an IV surgery concepts
Access to antibiotics
Press Release

Last-resort antibiotics remain out of reach in Latin America and the Caribbean, review warns

Read more
DNDi Comms GARDP NNS Jipmer Pondi Sept2019 Shatabdi17
Neonatal sepsis
Press Release

Landmark clinical trial to transform treatment options for newborns with sepsis expands to Asia

Read more
Thumbnail MMV GARDP DNDi PR2026 (1)
Corporate
Partners

DNDi, GARDP, and MMV join forces to accelerate drug development for patients in greatest need

Read more
Design banner
Statement

A Policy Brief for Member States: Strengthening Global Health Architecture Reform

Read more
New York, NY, U.S.A. – Headquarters of the United Nations: United Nations is an intergovernmental organization that aims to maintain international peace and security.
Statement

Why the IPEA Matters Now: A Policy Brief for Member States

Read more
HERA 3 funding
Corporate
Partners

The European Commission invests in CARB-X and GARDP to ramp up global response to antimicrobial resistance

Read more
High throughput screening
Corporate
Partners

Antabio and GARDP join forces to identify potential next-generation antibiotics

Read more
AdobeStock
Statement

GARDP revives clinical research into apramycin as potential treatment for life-threatening ‘superbugs’

Read more